The World Orphan Drug Congress Europe returns 27-29 October 2025 as the
largest and most established orphan drug & rare disease meeting of its kind!
From cell and gene therapy, genetic testing, and market access, to real world evidence, this one meeting covers the whole orphan drugs value chain where science, government and manufacturers all come together to create groundbreaking progress.
Limited FREE passes
are available for Ipsen employees in France and Netherlands, granting full access to the conference, including the workshop day, networking app and drink receptions.
Please note: all applications are subject to Terrapinn approval and availability. We also have the right to decline or withdraw your application at any time.
Ipsen will be contributing sessions across the
entire programme
– see who will be speaking below:
28 October
09:45
Martine Zimmerman
SVP Head of Regulatory & Quality Affairs
Keynote panel: New treatments on the block – 2025’s rare disease pipeline
11:45
Lisa Marsden (TBC)
SVP, Market Access
Access & Pricing
Access and HTA pathways for OMPs – do they improve access and drive incentive for innovation?
15:55
James A Levine
President, Foundation Ipsen
Investment & Funding
Ask the investors: How to attract interest and investment to your start-up
Offer applies to Ipsen employees only. All guest pass applications subject to Terrapinn approval.
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events